Syneron Medical Ltd (ELOS.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Syneron Medical receives China CFDA clearance for elure advanced skin brightening lotion


Monday, 21 Jul 2014 09:00am EDT 

Syneron Medical Ltd:Receives the China Food and Drug Administration (CFDA) clearance for its elure Advanced Skin Brightening Lotion.Elure skin brightening solution is a new cosmetic product originally available only from dermatologists, plastic surgeons and other medical aesthetic providers. 

Company Quote

7.39
0.12 +1.65%
24 Jun 2016